Council Directive 65/65/EEC of 26 January 1965 on the approximation of provisions laid down by law, regulation or administrative action relating to medicinal products(3), Council Directive 75/318/EEC of 20 May 1975 on the approximation of the laws of Member States relating to analytical, pharmaco-toxicological and clinical standards and protocols in respect of the testing of proprietary medicinal products(4), Council Directive 75/319/EEC of 20 May 1975 on the approximation of provisions laid down by law, regulation or administrative action relating to proprietary medicinal products(5), Council Directive 89/342/EEC of 3 May 1989 extending the scope of Directives 65/65/EEC and 75/319/EEC and laying down additional provisions for immunological medicinal products consisting of vaccines, toxins or serums and allergens(6), Council Directive 89/343/EEC of 3 May 1989 extending the scope of Directives 65/65/EEC and 75/319/EEC and laying down additional provisions for radiopharmaceuticals(7), Council Directive 89/381/EEC of 14 June 1989 extending the scope of Directives 65/65/EEC and 75/319/EEC on the approximation of provisions laid down by law, regulation or administrative action relating to medicinal products and laying down special provisions for proprietary medicinal products derived from human blood or human plasma(8), Council Directive 92/25/EEC of 31 March 1992 on the wholesale distribution of medicinal products for human use(9), Council Directive 92/26/EEC of 31 March 1992 concerning the classification for the supply of medicinal products for human use(10), Council Directive 92/27/EEC of 31 March 1992 on the labelling of medicinal products for human use and on package leaflets(11), Council Directive 92/28/EEC of 31 March 1992 on the advertising of medicinal products for human use(12), Council Directive 92/73/EEC of 22 September 1992 widening the scope of Directives 65/65/EEC and 75/319/EEC on the approximation of provisions laid down by law, regulation or administrative action relating to medicinal products and laying down additional provisions on homeopathic medicinal products(13) have been frequently and substantially amended. In the interests of clarity and rationality, the said Directives should therefore be codified by assembling them in a single text.
Recital 1, Directive (EU) 2001/83
Opinion of Advocate General Szpunar delivered on 20 May 2021. Pharma Expressz Szolgáltató és Kereskedelmi Kft v Országos Gyógyszerészeti és Decision
The system of EU rules governing the medicinal products for human use sector comprises a number of legislative texts, [For a more detailed description of EU pharmaceutical law, see Martens, M., Carbonelle, N., ‘The EU Regulatory …
20 May 2021 · 62020CC0178
Opinion of Advocate General Bot delivered on 12 June 2019. VIPA Kereskedelmi és Szolgáltató Kft. v Országos Gyógyszerészeti és Élelmezés-egéDecision
As a preliminary point, it should be noted, first, that Directive 2001/83 codified all the provisions in force relating to, amongst other matters, the sale and distribution of medicinal products for human use in the European Union. [See …
12 Jun 2019 · 62018CC0222
- celex=31965L0065
- celex=31975L0318
- celex=31975L0319
- celex=31989L0342
- celex=31989L0343
- celex=31989L0381
- celex=31992L0025
- celex=31992L0026
- celex=31992L0027
- celex=31992L0028